I hope everybody here realises that in PAA's case, even a disappointing trial result on covid will not derail the PAA show, because its main game, cancer treatment, is well on track and any negative news on the covid will only have a temporary negative impact on the company's valuation imo. That said, the covid case looks very promising, but I think we should all look at it as an unexpected bonus and not as PAA's main game, which is going very well imo. This is why I'm not worried at all.
dyor and be sensible
GLTAHs
MPL Verses CV-19 Results : 100% Successful in treating TWO patients In California USA., page-317
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NUZ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.010(5.26%) |
Mkt cap ! $98.34M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.5¢ | 19.5¢ | $86.20K | 429.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 67508 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 36444 | 3 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| NUZ (ASX) Chart |